Molecular Imaging 2017

74 Pca pts referred for first radiotherapy (primary or recurrent tumor)

Cho-PET/CT changed the treatment approach in 27% of cases compared with standard treatment that would have been adopted without cho-PET/CT. Cho-PET/CT is valuable in defining the extent of disease and supporting therapeutic decisions in the management of prostate cancer.